How to Administer Methylcobalamin Injection
Methylcobalamin should be administered intramuscularly at doses ranging from 500 mcg to 1500 mcg, with frequency depending on the clinical indication—typically 500 mcg three times weekly for peripheral neuropathy or up to 50 mg twice weekly for specific neurological conditions like ALS.
Administration Technique
Based on FDA-approved protocols 1, the injection technique involves:
Route: Intramuscular (IM) injection
Equipment needed 1:
- 1 mL syringe with Luer-Lok tip
- 22G x 1" needle for drawing medication
- 30G x 1" needle for administration
- Alcohol prep pads
- Sterile gloves
- Adhesive bandage
Injection sites: Standard IM sites (deltoid, vastus lateralis, or ventrogluteal muscle)
Absorption: Peak plasma levels occur within 1 hour after IM injection 1
Dosing Protocols by Indication
For Peripheral Neuropathy
The 500 mcg three times weekly regimen is superior to once-weekly dosing 2. Research demonstrates that 500 mcg IM three times weekly produces significantly higher serum cobalamin levels (1892 ng/L) compared to 1500 mcg once weekly (1438 ng/L) after treatment completion (P = 0.028) 2. This more frequent dosing also provides better pain relief and functional improvement 3.
For Vitamin B12 Deficiency
Standard treatment involves:
- Initial phase: 500-1000 mcg IM daily or every other day for 1-2 weeks
- Maintenance: Weekly to monthly injections depending on underlying cause
- Duration continues until deficiency is corrected and symptoms resolve
For Neurological Conditions (ALS)
Ultra-high-dose protocols have shown efficacy:
- 50 mg IM twice weekly for patients with early-stage ALS (within 1 year of onset) 4
- This regimen slowed functional decline by approximately 2 points on ALSFRS-R over 16 weeks compared to placebo (P = 0.01) 4
- Long-term safety confirmed up to 52 weeks with minimal adverse effects 5
Important Clinical Considerations
Absorption and Storage
- IM administration bypasses the need for intrinsic factor, making it essential for patients with pernicious anemia or malabsorption 1
- 50-98% of injected dose appears in urine within 48 hours, with most excreted in first 8 hours 1
- Liver stores approximately 2500 mcg in healthy adults, lasting 12-36 months 6
Common Pitfalls to Avoid
- Timing of blood draws: Sample for serum cobalamin levels BEFORE injection to avoid falsely elevated results 6
- Injection site reactions: Minor pain and hematoma at injection sites are the most common adverse effects 3
- Inadequate frequency: Once-weekly dosing is less effective than three-times-weekly for raising serum levels 2
Safety Profile
Methylcobalamin demonstrates excellent safety even at ultra-high doses:
- Adverse drug reactions occur in only 3.5% of patients at 50 mg doses 5
- No serious adverse events leading to discontinuation or death reported 5
- Water-soluble nature allows rapid renal excretion of excess 1
Alternative Routes
While IM is standard, subcutaneous administration is equally effective and may be preferred for:
- Patients requiring long-term therapy
- Those with bleeding disorders
- Self-administration at home
The subcutaneous route provides similar bioavailability to IM injection 1.